Other OTC - Delayed Quote • USD
Nemaura Medical Inc. (NMRD)
At close: April 23 at 3:19 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.11 | -0.11 | -0.32 | -0.44 |
| Low Estimate | -0.11 | -0.11 | -0.32 | -0.44 |
| High Estimate | -0.11 | -0.11 | -0.32 | -0.44 |
| Year Ago EPS | -0.18 | -0.09 | -0.57 | -0.32 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 200k | 200k | 200k | 1.4M |
| Low Estimate | 200k | 200k | 200k | 1.4M |
| High Estimate | 200k | 200k | 200k | 1.4M |
| Year Ago Sales | -- | -- | 77k | 200k |
| Sales Growth (year/est) | -- | -- | 159.70% | 600.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.15 | -0.11 | -0.12 |
| EPS Actual | -0.18 | -0.09 | -0.05 | -0.07 |
| Difference | -0.02 | 0.06 | 0.06 | 0.05 |
| Surprise % | -12.50% | 40.00% | 54.50% | 41.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.11 | -0.11 | -0.32 | -0.44 |
| 7 Days Ago | -0.11 | -0.11 | -0.32 | -0.44 |
| 30 Days Ago | -0.11 | -0.11 | -0.32 | -0.44 |
| 60 Days Ago | -0.11 | -0.11 | -0.32 | -0.44 |
| 90 Days Ago | -0.11 | -0.11 | -0.36 | -0.43 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NMRD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 38.90% | -- | -- | 0.30% |
| Next Qtr. | -22.20% | -- | -- | 9.80% |
| Current Year | 43.90% | -- | -- | 4.50% |
| Next Year | -37.50% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.06% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/21/2023 |
| Maintains | EF Hutton: Buy to Buy | 7/17/2023 |
| Reiterates | EF Hutton: Buy | 3/30/2023 |
| Maintains | EF Hutton: Buy | 2/28/2023 |
| Maintains | HC Wainwright & Co.: Buy | 2/27/2023 |
| Maintains | HC Wainwright & Co.: Buy | 8/19/2022 |
Related Tickers
SRDX Surmodics, Inc.
26.92
+6.03%
XTNT Xtant Medical Holdings, Inc.
0.9090
+8.21%
VTAK Catheter Precision, Inc.
0.4557
+2.40%
TNON Tenon Medical, Inc.
0.7101
-4.04%
IRIX IRIDEX Corporation
3.0300
+3.77%
NCYT.L Novacyt S.A.
69.10
+1.61%
ICAD iCAD, Inc.
1.5600
+2.63%
THMO ThermoGenesis Holdings, Inc.
0.6900
+6.15%
AXDX Accelerate Diagnostics, Inc.
0.9500
+7.05%
AIMD Ainos, Inc.
1.0200
+0.99%